Table of Contents
1 Industry Outlook 10
1.1 Patient Demographics 12
1.2 Healthcare Spending in the US 14
1.3 Definition: Insulin Pump 14
1.4 Diabetic Overview 15
1.5 Insulin Pump Definition - Infoholic Research 15
1.6 Importance of Insulin Pump 16
1.7 Industry Trends 16
1.8 Pest Analysis 17
2 Report Outline 18
2.1 Report Scope 18
2.2 Report Summary 18
2.3 Research Methodology 19
2.4 Report Assumptions 19
3 Market Snapshot 21
3.1 Total Addressable Market (TAM) 21
3.2 Segmented Addressable Market (SAM) 23
3.3 China Insulin Pump Market 26
3.4 Healthcare in China 27
3.5 Competitive Scenario 29
3.6 Related Markets 30
3.6.1 Ultrasound Devices 30
3.6.2 Medical X-ray Equipment 30
3.6.3 MRI Equipment 30
3.7 Porter 5(Five) Forces 31
4 Market Characteristics 32
4.1 Evolution 32
4.2 Insulin Pumps Therapy Advantages 33
4.3 Insulin Pumps Therapy Disadvantages 33
4.4 Role of Insulin Pumps in Healthcare 33
4.5 Market Dynamics 34
4.5.1 Drivers 34
4.5.1.1 Huge Surge in Aging Population 34
4.5.1.2 Increase in Awareness 35
4.5.1.3 Increasing Number of Diabetic Patients 35
4.5.1.4 Rising Incidences of Government Initiatives 35
4.5.2 Opportunities 36
4.5.2.1 Technological advances in insulin pump 36
4.5.2.2 Insulin Pumps replacing traditional Methods 36
4.5.2.3 Increasing partnership and collaboration activities 36
4.5.2.4 Focus on early diabetes management 36
4.5.2.5 Rapid growth in emerging countries 37
4.5.3 Restraints 37
4.5.3.1 High price of latest insulin pumps 37
4.5.3.2 Unfavorable reimbursement plans 37
4.5.3.3 Availability of substitutes 38
4.5.3.4 Competition among major vendors 38
4.5.4 DRO - Impact Analysis 38
4.5.5 Key Stakeholders 40
5 Types: Market Size and Analysis 41
5.1 Overview 41
5.2 Tethered insulin pump 42
5.3 Untethered insulin pumps 42
5.4 Implantable insulin pump 42
6 End User: Market Size and Analysis 43
6.1 Overview 43
6.2 Hospitals 44
6.3 Homecare 44
6.4 Clinics 44
6.5 Others (nursing homes and medical offices) 44
7 Regions: Market Size and Analysis 46
7.1 Overview 46
7.2 North America 47
7.3 Europe 49
7.4 APAC 50
7.5 Rest of the World 51
8 Market Attractiveness 54
8.1 Market Attractiveness by Products 54
8.2 Market Attractiveness by End Users 55
9 Competitive Landscape 57
9.1 Overview 57
10 Product Matrix 58
11 Vendor Profiles 60
11.1 Insulet Corp. 60
11.1.1 Overview 60
11.1.2 Business Unit 63
11.1.3 Geographic Presence 63
11.1.4 Business Focus 64
11.1.5 SWOT Analysis 64
11.1.6 Business Strategy 65
11.2 Medtronic Plc 66
11.2.1 Overview 66
11.2.2 Business Unit 75
11.2.3 Geographic Presence 77
11.2.4 Business Focus 77
11.2.5 SWOT Analysis 78
11.2.6 Business Strategy 78
11.3 MicroPort Scientific Corporation 79
11.3.1 Overview 79
11.3.2 Business Units 81
11.3.3 Geographic Presence 82
11.3.4 Business Focus 82
11.3.5 SWOT Analysis 83
11.3.6 Business Strategies 84
11.4 F.Hoffmann-La Roche Ltd 85
11.4.1 Overview 85
11.4.2 Business Unit 90
11.4.3 Geographic Presence 90
11.4.4 Business Focus 91
11.4.5 SWOT Analysis 91
11.4.6 Business Strategy 92
11.5 Tandem Diabetes Care' Inc 93
11.5.1 Overview 93
11.5.2 Business Focus 96
11.5.3 SWOT Analysis 96
11.5.4 Business Strategy 96
12 Companies to Watch For 97
12.1 Eli Lilly and Company 97
12.1.1 Overview 97
12.2 Animas Corp. 98
12.2.1 Overview 98
12.3 Sooil Development Co.' Ltd. 100
12.3.1 Overview 100
12.4 Ypsomed Holding AG 101
12.4.1 Overview 101
12.5 Valeritas' Inc 102
12.5.1 Overview 102
12.6 GlySens ICGM 103
12.6.1 Overview 103
Annexure 104
12.7 Abbreviations 104